J. Møss

发表

Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9‐GP), a glycoPEGylated recombinant factor IX

P. Collins, K. Knobe, T. Colberg, 2012, Journal of thrombosis and haemostasis : JTH.

Evaluation of the safety and pharmacokinetics of a fast‐acting recombinant FVIIa analogue, NN1731, in healthy male subjects

B. Scharling, M. Ezban, J. Møss, 2009, Journal of thrombosis and haemostasis : JTH.

Safety and pharmacokinetics of a glycoPEGylated recombinant activated factor VII derivative: a randomized first human dose trial in healthy subjects

A. Rosholm, J. Møss, A. Lauren, 2011, Journal of thrombosis and haemostasis : JTH.